Cargando…
Immunoregulation and antidepressant effect of ketamine
Major depressive disorder (MDD) is a common mental health disorder that brings severe disease burden worldwide. Traditional antidepressants are mainly targeted at monoamine neurotransmitters, with low remission rates and high recurrence rates. Ketamine is a noncompetitive glutamate N-methyl-d-aspart...
Autores principales: | Zhang, Nan, Yao, Lihua, Wang, Peilin, Liu, Zhongchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155793/ https://www.ncbi.nlm.nih.gov/pubmed/34079622 http://dx.doi.org/10.1515/tnsci-2020-0167 |
Ejemplares similares
-
The Ketamine Antidepressant Story: New Insights
por: Alshammari, Tahani K.
Publicado: (2020) -
The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020) -
Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect
por: Stenovec, Matjaž
Publicado: (2021) -
Macrophages in immunoregulation and therapeutics
por: Chen, Shanze, et al.
Publicado: (2023) -
Immunoregulation in Fungal Diseases
por: Roussey, Jonathan A., et al.
Publicado: (2016)